Shanghai-based immunotherapy firm CARsgen says it has completed an undisclosed amount of series A financing led by Shanghai-based BVCF, a growth capital-focused private equity fund specializing in the life sciences industry, according to a company announcement. CARsgen focuses on the development of new therapeutics for liver, lung, stomach and brain cancers. In collaboration with Shanghai […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.